LAKE OSWEGO, Ore., Sept. 27, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Rosemary Mazanet, M.D., Ph.D., Executive Vice President and Chief Medical Officer, will present a corporate overview at the 3rd Annual Cancer Immunotherapy: A Long-Awaited Reality Conference. The presentation will take place on Thursday, October 4, 2012 at 9:00 a.m. EDT at the New York Academy of Medicine in New York, NY.
The presentation will be webcast and available on the Company's website at http://investors.galenabiopharma.com/events.cfm .
About Galena BiopharmaGalena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com . The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647
CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 email@example.com or Remy Bernarda IR Sense, LLC +1 (415) 203-6386 firstname.lastname@example.org